Cubist Systematic Strategies, LLC Kempharm, Inc Transaction History

Cubist Systematic Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	N/A	468 New	468 $2,000
Q3 2022 Nov 14, 2022	SELL	$4.5 - $6.85 $45,756 - $69,650	-10,168 Reduced 33.96%	19,771 $123,000
Q2 2022 Aug 15, 2022	BUY	$4.02 - $5.21 $120,354 - $155,982	29,939 New	29,939 $134,000
Q1 2022 May 16, 2022	SELL	$5.0 - $9.26 $121,865 - $225,693	-24,373 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.6 - $10.26 $71,645 - $96,721	9,427 Added 63.07%	24,373 $212,000
Q3 2021 Nov 15, 2021	BUY	$8.72 - $13.31 $30,894 - $47,157	3,543 Added 31.07%	14,946 $139,000
Q2 2021 Aug 16, 2021	BUY	$8.52 - $15.47 $97,153 - $176,404	11,403 New	11,403 $146,000

116

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.